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Abstract The expression of myf-5, a key component of
myogenic regulatory genes, declines progressively in mature
somitic cells during vertebrate myogenesis. Little is known about
how this down-regulation takes place. Here we provide evidence
that an interferon regulatory factor binding element (IRF
element) within the Xenopus myf-5 promoter is responsible for
the elimination of myf-5 transcription in mature somitic
mesoderm of Xenopus embryos. We show that this IRF element
mediates the down-regulation of Xmyf-5 transcription in gastrula
embryos, and can specifically interact with nuclear proteins of
early neurula. Moreover, deletion of this IRF element results in
the anterior expansion of reporter gene transcripts within somitic
mesoderm in transgenic embryos. Our results, therefore, provide
insight into how the negative control of Xmyf-5 expression takes
place. ß 2001 Federation of European Biochemical Societies.
Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Vertebrate myogenesis is mainly controlled by members of
the myogenic regulatory factor (MRF) family, including
MyoD, Myf-5, myogenin and MRF4, which are all basic he-
lix-loop-helix transcriptional factors [1^3]. Among these four
genes, myf-5 and myoD are expressed earlier than myogenin
and MRF4, and are therefore believed to play a central role in
initiating myogenesis [4]. Mice lacking both myf-5 and myoD
die at birth without detectable skeletal muscle or myoblast
[5,6], though mice with a targeted knockout of either myf-5
or myoD alone are capable of forming at least some myo¢ber
[7]. In Xenopus laevis, ectopic expression of myf-5 activates
both myoD and the cardiac actin gene in animal cap cells
[8]. When myf-5 is overexpressed together with Xenopus
myoD it can also induce enlarged cranial and anterior trunk
myotome myocytes and ectopic muscles in the lateral plate
and neural tissue [9]. These results suggest that myf-5,
although it has redundant function with myoD, is a muscle
initiator.
The expression pattern of myf-5 is thought to be consistent
with its role during the early determination of the myogenic
lineage. In Xenopus, myf-5 is ¢rst activated in the dorsal re-
gion of stage 10 embryos [10,11]. Soon after the onset of
gastrulation, the Xenopus myf-5 (Xmyf-5) expression domain
shifts to the dorso-lateral marginal zone which is believed to
give rise to the anterior somitic mesoderm [9^16]. As gastru-
lation goes on, Xmyf-5 expression in the future anterior so-
mitic mesoderm is progressively down-regulated via an un-
known mechanism, and myf-5 transcripts are restricted to
the posterior part of the somitic mesoderm [9,11,12]. This
character is maintained to tadpole stage with positive signals
restricted within the tail [12]. Given that somite formation and
maturation in Xenopus follow the antero-posterior sequence,
the dynamic change of Xmyf-5 expression pattern is coinci-
dent with the process of somitogenesis. A similar observation
was made in mouse myogenesis where myf-5 is activated in
newly formed somites prior to the expression of any other
muscle regulatory genes and is then down-regulated parallel
with the maturation of somites in an anterior-to-posterior
order [17].
The dynamic change of the myf-5 expression pattern thus
implies that myf-5 activity may be only required for the early
determination of muscle cells. Precise down-regulation of myf-
5, followed by the activation of other myogenic regulatory
genes such as myogenin and MRF4, therefore, might be cru-
cial for the initiation of myogenic di¡erentiation. The ques-
tion we ask here is, how does this precise elimination of Xmyf-
5 occur.
In this paper, we report our identi¢cation of a repressor in
the Xmyf-5 promoter which matches the consensus sequence
of the interferon (IFN) regulatory factor (IRF)-like binding
element. We show that this putative IRF binding site mediates
the down-regulation of Xmyf-5 transcription in gastrula em-
bryos, and can be bound speci¢cally by nuclear proteins of
stage 15 embryos. Moreover, deletion of this putative IRF
binding site in Xmyf-5 promoter results in anterior expansion
of reporter gene expression in transgenic embryos. Our re-
sults, therefore, provide insight into how the negative control
of Xmyf-5 takes place.
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2. Materials and methods
2.1. Construction of plasmids
p(31869/330)Luc/p(31869/330)GFP and pvIRFLuc/pvIRFGFP:
The 1.8 kb promoter of the Xmyf-5 5P upstream region from 31869
bp to 330 bp was enzyme digested from the 4.858 kb promoter (FL/
SK) we previous reported [18] with NcoI (blunted by mung bean
nuclease) and HindIII, and was then inserted into the SmaI and Hin-
dIII site of pGL3-basic vector to generate p(31869/330)Luc.
pvIRFLuc was generated as follows: Two fragments (31872/
31410, 31399/3811) were PCR ampli¢ed (primers for ampli¢cation:
upstream, 5P-ttccatgggagatcatctttgcctg-3P, downstream, 5P-cctctaga-
aatcttcccctctgtgt-3P ; upstream, 5P-tcctctagagactccaggagcagct-3P, down-
stream, 5P-taggatccattgtccggaaacccag-3P). The two fragments were
digested with XbaI and ligated and inserted into the NcoI and BglII
frame of pGL3 Basic to make pvIRF(31872/3811). After sequencing,
pvIRF(31872/3811) was used to replace the sequence from 31872
bp to 3811 bp in the wild type Xmyf-5 promoter to generate
pvIRFSK. And the NcoI and HindIII frame of this mutant promoter
was further inserted into the SmaI and HindIII site of pGL3-basic to
generate pvIRFLuc.
Construction of pvIRFGFP and p(31869/330)GFP: For transgen-
ic reporter gene assays, the luciferase gene of p(31869/330)Luc was
removed with XbaI and HindIII, and replaced by a GFP cDNA[19] to
generate p(31869/330)GFP. pvIRFGFP was generated by removing
the vIRF fragment (31869/330) from pvIRFSK with SacI and Hin-
dIII and cloned into the SacI and HindIII sites of p(31869/330)GFP.
Construction of TK-basicLuc, p(31869/3819)TK Luc and 5P or 3P
deletion constructs: TK-basicLuc was generated by inserting the TK
promoter sequence of PRL-TK [20] (BglII and HindIII frame) into
the BglII and HindIII sites of pGL3-basic. p(31869/3819)TKluc was
generated by restriction enzyme through releasing the 1.05 kb (31869/
3819) fragment from p(31869/330)Luc with SacI and BamHI and
then inserting it into SacI and BglII sites of TK-basicLuc.
Either 5P or 3P deletion constructs of p(31869/3819)TKLuc were
further generated according to the restriction sites located within the
1.05 kb fragment: p(31752/3819)TKLuc by EcoRV, p(31042/
3819)TKLuc by AccI, p(31869/31158)TKLuc by AccI and
p(31869/31753)TKLuc by EcoRV.
The 5P or 3P deletion constructs on the basis of the sequence from
31752 bp to 31158 bp were PCR ampli¢ed (primers for 5P deletion
constructs: upstream, 5P-caaagagttcctgcaccttg-3P for p(31557/31158)-
TKLuc, 5P-tcctaagagaggcatcgcgg-3P for p(31359/31158)TKLuc;
downstream, T3 primer. Primers for 3P deletion constructs: upstream,
T7 primer; downstream, 5P-ccgcgatgcctctcttagga-3P for p(31752/
31340)TKLuc; 5P-caaggtgcaggaactctttg-3P for p(31752/31538)-
TKLuc). The PCR ampli¢ed sequences were further digested with
either BamHI or KpnI and inserted into the KpnI (blunted by mung
bean nuclease) and BglII sites of TK-basicLuc to generate p(31557/
31158)TKLuc and p(31359/31158) TKLuc or inserted into the KpnI
and BglII (Klenow) sites of TK-basicLuc to generate p(31752/
31340)TKLuc and p(31752/31538)TKLuc.
2.2. Transgenesis and whole-mount in situ hybridization
Transgenic Xenopus embryos were generated as described by Kroll
and Amaya through restriction enzyme-mediated integration (REMI)
[21]. Plasmids used for transgenesis were linearized by NotI digestion.
In situ hybridizations were performed as described by Epstein [22].
2.3. Xenopus embryo manipulation and luciferase assay
Eggs were obtained from Xenopus females, fertilized in vitro and
cultured as described [23]. Embryonic stages were determined as de-
scribed previously [24].
A plasmid solution of 5 nl containing 10 pg/nl of promoter con-
structs and 10 pg/nl of internal control pRL-SV40 (Promega product)
was injected into the dorsal-lateral equatorial region of four-cell stage
embryos. Injected embryos were harvested at stage 12.5 and luciferase
assays were performed according to the instruction of the Dual-Lu-
ciferase TM Reporter Assay System (Promega product). Ten embryos
were collected for each measurement and embryos from the same
fertilization batch were used for each experiment. Each results was
repeated at least three times independently.
2.4. Electrophoresis mobility shift assays (EMSA)
The probe for EMSA was end-labeled with the standard method.
The single strand sequence of the probe was: 5P-aggggaagatttcttcacttc-
cactagaga-3P. Nuclear extracts were prepared from Xenopus embryos
at stage 15 [25]. 15 Wg nuclear extract, 2 Wg poly(dI-dC) (Pharmacia
Biotech) and 4.5 Wg bovine serum albumin and various amounts of
cold probe (competitor) were mixed and incubated at 25‡C for 15 min.
Approximately 1 ng probe was added into each reaction and incu-
bated at 25‡C for another 25 min. The ¢nal concentration of the
working solution was 40 mM KCl, 15 mM HEPES (pH 7.9), 1 mM
EDTA, 0.5 mM dithiothreitol and 5% glycerol. The reaction products
were immediately loaded on a 5% PAGE gel containing 0.5UTBE.
Gels were then exposed to X-ray ¢lms.
3. Results
3.1. The 2.0 kb Xmyf-5 5P upstream DNA contains a repressor
Previously we reported our isolation of a 4.858 kb Xmyf-5
upstream DNA (GenBank, accession number AF212160) and
analysis of reporter gene activity directed by serial deletion
fragments of the 4.858 kb sequence in late gastrula embryos
(stage 12.5) [18]. We mark the ‘A’ of the ATG start codon of
the open reading frame (ORF) as ‘1’. We showed that the
1.05 kb sequence from 31869 to 3819 bp could reduce re-
porter gene activity, implying that the 1.05 kb fragment might
contain a repressor element [18]. To test whether the 1.05 kb
sequence (31869/3819) could play a transcriptional repressive
role in a heterologous promoter context, we inserted the
1.05 kb sequence upstream to the TK promoter (see Section
2) for the luciferase assay (Fig. 1A). Two constructs, p(31869/
3819)TKLuc and pTK-basicLuc, were injected into the dor-
Fig. 1. The 1.05 kb DNA sequence (31869/3819) of the Xmyf-5
promoter contains a repressive regulatory element. A: Schematic di-
agram of p(31869/3819)TKLuc and TK-BasicLuc. Solid rectangle,
TK promoter; open rectangle, the open reading frame of the lucifer-
ase gene. B: The cis-element within the sequence from 31869 bp to
3819 bp plays a repressive role in a heterologous context. Con-
structs were injected into the dorsal-lateral marginal zone of four-
cell stage embryos and harvested at stage 12.5 for luciferase activity.
The experiment was independently repeated three times, and a rep-
resentative result is shown. Each bar is the mean of three replica-
tes+S.D.
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sal-lateral marginal zone of four-cell stage embryos and the
reporter gene activities were measured in stage 12.5 when
endogenous Xmyf-5 peaks. As shown in Fig. 1B, luciferase
activities from p(31869/3819)TKLuc-injected embryos only
reached about 30% of control embryos injected with pTK-
basicLuc. These results suggested that a repressor is located
within the 1.05 kb sequence (31869/3819) which could be-
have similarly in the heterologous promoter context as in the
Xmyf-5 promoter: it led to an inhibition of transcriptional
activity.
3.2. An IRF-like binding element within the Xmyf-5 promoter
region plays a repressive role in the transcriptional
regulation of Xmyf-5
To address which sequence within this 1.05 kb fragment
might mediate the repressor activity, serial deletion constructs
were generated on the basis of p(31869/3819)TKLuc accord-
ing to the naturally occurring restriction sites located within
the 1.05 kb sequence (Fig. 2A), and their activities were tested
in the dorsal-lateral marginal zone as described above. As
shown in Fig. 2B, reporter constructs containing the 595 bp
sequence between 31752 and 31158 bp (p(31752/
3819)TKLuc and p(31869/31158)TKLuc) showed signi¢-
cantly lower activities than those without this 595 bp sequence
(p(31042/3819)TKLuc and p(31869/31753)TKLuc). There-
fore, the repressor of interest is likely located within this 595
bp fragment (31752/31158 bp). We thus generated further
deletion constructs by PCR on the basis of this 595 bp se-
quence and again assayed the reporter gene activities in the
late gastrula stage (Fig. 2A). Signi¢cantly, the activities of two
reporter constructs, p(31752/31340)Luc and p(31557/
31158)Luc, were remarkably lower than those of the other
two reporter constructs, p(31752/31538)Luc and p(31359/
31158)Luc, suggesting that the 198 bp fragment from
31557 bp to 31360 bp is indispensable for the repressive
activity (Fig. 2C). Thus, the 198 bp sequence (31557/
Fig. 2. An IRF element within the 1.05 kb Xmyf-5 upstream sequence plays a repressive role in the regulation of Xmyf-5 in late gastrula em-
bryos. A: Diagram of Xmyf-5 promoter deletion constructs used in this study. Each horizontal line represents the relative length of the up-
stream sequence of Xmyf-5. Each deletion fragment was fused upstream to a luciferase reporter gene driven by TK promoter. B: 595 bp se-
quence between 31752 bp and 31158 bp represses reporter gene activities directed by TK promoter. C: 198 bp sequence between 31557 bp to
31360 bp is su⁄cient to decrease reporter gene activities directed by the TK promoter. D: An IRF element (31409/31404) within the Xmyf-5
upstream sequence signi¢cantly decreases transcriptional activity of Xmyf-5. Luciferase assay was performed as described in Fig. 1.
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31360) of Xmyf-5 upstream contains a cis-regulatory element
which mediates the transcriptional repression of Xmyf-5 in
late gastrula.
Consensus sequences of several known cis-regulatory ele-
ments were found in this 198 bp fragment (31557 bp/31360
bp). Among them, 5P-TTCACT-3P (31409/31404) matches
the consensus of the IRF element perfectly [26,27]. The IRF
element has been classically found in the promoters of IFN-K
and IFN-L, and can act as either enhancer or repressor
through interacting with transcriptional factors of the IRF
family [26,28^31]. And IRF elements have been identi¢ed
from promoters of several genes other than IFN-K and IFN-
L [32]. Recently, an IRF element within the vascular cell ad-
hesion molecule-1 (VCAM-1) promoter has been identi¢ed to
mediate the transcriptional activation of VCAM-1, which is
important for mouse myogenesis. This observation raises the
possibility that the putative IRF element might be responsible
for the down-regulation of Xmyf-5 in gastrula embryos. To
address this hypothesis, we generated the construct pvIRFLuc
in which the putative IRF element was removed (see Section
2). Interestingly, when the reporter gene activity was tested in
late gastrula embryos, embryos injected with pvIRFLuc in-
deed showed a higher reporter gene activity (about four-fold)
than that of control embryos injected with p(31869/330)Luc
(Fig. 2D). These results thus suggested that this putative IRF
binding site in Xmyf-5 promoter may act as a transcriptional
repressor to down-regulate Xmyf-5 activity in the late gastrula
stage.
3.3. The IRF element can speci¢cally interact with nuclear
proteins of early neurula
Transcriptional regulation often needs physical interaction
between the transcriptional regulator and its speci¢c binding
site. To address whether the IRF element we isolated in the
Xmyf-5 upstream region is involved in protein^DNA interac-
tion during myogenesis, we performed EMSA. A probe with
sequence encompassing the putative IRF element was used
(see Section 2). As shown in Fig. 3, this probe was bound
by nuclear proteins extracted from nuclei of early neurula
(stage 15), as judged by three shift complexes. These interac-
tions are speci¢c, since increasing amount of competitor, the
‘cold’ probe, was able to interfere with the binding between
the ‘hot’ probe and the nuclear proteins. The probe^protein
complex was signi¢cantly reduced or completely abolished
when 100- or 1000-fold of the competitor was incubated
with the nuclear protein before the hot probe was added,
respectively (Fig. 3). The EMSA data, therefore, indicated
that this putative IRF binding element mediates the down-
regulation of Xmyf-5 probably through the speci¢c interaction
with nuclear proteins of early neurula.
3.4. The IRF element is su⁄cient to eliminate Xmyf-5 activity
in the anterior somitic mesoderm
To address the functional signi¢cance of this IRF element
during the ¢ne spatial patterning of Xmyf-5 expression, we
used REMI to introduce GFP reporter constructs (p(31869/
330)GFP and pvIRFGFP) into the embryos [21]. Expression
of GFP was detected by in situ hybridization in stage 12.5
when endogenous Xmyf-5 begins its posterior localization
within the presomitic mesoderm, and stage 30.
Fig. 3. The IRF element within the Xmyf-5 promoter region speci¢-
cally interacts with the nuclear proteins from early neurula (stage
15). A copy of the sequence from 31422 bp to 31393 bp of Xmyf-
5 upstream DNA that encompassed the IRF element was radiola-
beled and then incubated with nuclear extract from stage 15 em-
bryos. Three probe^protein complexes were resolved by gel electro-
phoresis. Shift bands are denoted by arrows. When in the presence
of the ‘cold’ probe as competitor, 1000-fold molar excess of ‘cold’
probe completely blocks the formation of complex between nuclear
proteins and the ‘hot’ probe.
  
  
Fig. 4. The IRF element within the Xmyf-5 promoter region is re-
sponsible for the elimination of Xmyf-5 activity in the anterior part
of the somitic mesoderm. A, B: GFP signal exhibits a posterior lo-
calization expression pattern in p(31869/330)GFP REMI embryos.
GFP was detected in the posterior part of the presomitic mesoderm
of late gastrula (A); dorsal view with anterior facing up. At tadpole
stage, GFP signal appears in the tail region (B). C, D: Removing
the IRF element from the Xmyf-5 promoter results in GFP signal
extending anteriorly within the somitic mesoderm in pvIRFGFP
REMI embryos. GFP signal spreads to the anterior part of the so-
mitic mesoderm at late gastrula and signal occupies the whole so-
mitic mesoderm adjacent to the notochord with some signal in the
neural ectoderm (C). Dorsal view with anterior facing up. GFP is
expressed both in the trunk somites and in those in the tail region
at tadpole stage with some signal in the eyes (D).
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In p(31869/330)GFP REMI embryos, GFP transcripts
were restricted to the posterior somitic mesoderm at stage
12.5 (Fig. 4A). In keeping with the posterior restriction of
reporter gene expression, GFP signal was visible in the tail
region of the tadpole stage embryos (Fig. 4B). The posterior
localization of reporter gene transcripts within the presomitic
mesoderm in p(31869/330)GFP REMI embryos at these
stages is quite similar to endogenous Xmyf-5 mRNA in nor-
mal embryos [12].
In contrast, the GFP expression pattern in pvIRFGFP
REMI embryos is impressively distinct from the pattern in
p(31869/330)GFP REMI embryos. As shown in Fig. 4C,
GFP signal in pvIRFGFP REMI embryos spread to the an-
terior part of the presomitic mesoderm in late gastrula and the
signal occupied the whole somitic mesoderm laterally localized
to the notochord. The GFP signal extended even very ante-
riorly, to the tissue that might be the rostral neural ectoderm
(Fig. 4C). Consistent with the observation that GFP signal
could extend anteriorly in late gastrula, GFP was detected
in both the trunk somites and those in the tail region at tad-
pole embryos with some signal in the eyes, a rostral neural
ectoderm derivative (Fig. 4D).
Notably, these stage-speci¢c expression patterns were ob-
served in the vast majority of pvIRFGFP REMI embryos
(10/16) and p(31869/330)GFP REMI embryos (15/19), with
almost no apparent ectopic expression.
By comparing the GFP expression patterns in p(31869/
330)GFP and pvIRFGFP REMI embryos, we concluded
that the IRF-like binding element within the 1.8 kb (31869/
330) Xmyf-5 promoter region is su⁄cient to eliminate Xmyf-5
activity in the anterior somitic mesoderm. The transgenic re-
sult also indicated that the IRF element might be required for
the exclusion of Xmyf-5 transcripts from the neural ectoderm.
4. Discussion
As one of the key components of myogenic regulatory
genes, Xmyf-5 is expressed persistently in the muscle precursor
cells during myogenesis, like other members of the myogenic
regulatory gene family [9^12]. However, the transcripts of
Xmyf-5 are more posteriorly localized than those of other
members of myogenic regulatory genes. The posterior restric-
tion of Xmyf-5 expression ¢rst appears at late gastrula, and
peaks at neurula, when Xmyf-5 transcripts can only be de-
tected in the presumptive tail region [9]. The loss of Xmyf-5
transcripts is correlated with di¡erentiation of determined
muscle cells. There are two possible mechanisms that control
this posterior restriction of Xmyf-5 expression: the anterior
muscle lineage may gradually lose the activator of Xmyf-5,
or a transcriptional repressor of Xmyf-5 may be progressively
turned on during myogenesis.
The results of our study provide the ¢rst direct evidence to
support the second hypothesis. We show that an IRF element
within 1.8 kb (31869/330) of the Xmyf-5 promoter region is
responsible for the elimination of Xmyf-5 transcripts in the
anterior somitic mesoderm. Our conclusion comes from the
following four results. First, transgenic results show that the
1.8 kb (31869/330) Xmyf-5 promoter can direct reporter gene
expression in the posterior somitic mesoderm. And loss of the
IRF element within the 1.8 kb Xmyf-5 promoter region leads
to reporter gene transcripts extending to the anterior somitic
mesoderm. Moreover, the deletion of the IRF element from
the 1.8 kb Xmyf-5 promoter results in a signi¢cant increase of
Xmyf-5 reporter construct activity in late gastrula embryos.
Finally, the nuclear proteins of early neurula speci¢cally bind
to this IRF element. Interestingly, when the probe encompass-
ing the IRF element was incubated with nuclear proteins of
late gastrula, only very weak binding was observed (data not
shown), indicating that the formation of IRF element^protein
complex is developmentally regulated. In other words, tran-
scriptional regulators responsible for the elimination of Xmyf-
5 activity through the IRF element may be activated from
gastrula and their activities keep on increasing during neurula
when endogenous Xmyf-5 transcripts are strongly decreased in
the anterior somites. Taken together, these data evidently
demonstrate that the IRF element is su⁄cient for repressing
Xmyf-5 in the anterior somitic mesoderm during myogenesis.
The posterior restriction expression pattern of the reporter
gene under the control of the 1.8 kb (31869/330) Xmyf-5
promoter is quite similar to the endogenous Xmyf-5 gene dur-
ing myogenesis [8,11,12]. Our identi¢cation and functional
analysis of cis-regulatory elements required for the dorsolat-
eral activation of Xmyf-5 at early gastrula will be published
elsewhere.
Given that IRF-2 protein is important for mouse muscle
cell development through regulating expression of VCAM-1,
though it acts as a transcriptional activator there, we cannot
exclude the possibility that the nuclear protein binding to the
IRF element within the Xmyf-5 upstream region is one of the
IRF family members, like IRF-2 [32]. Further studies are
required to determine the identities of proteins interacting
with the IRF element within the Xmyf-5 promoter and the
relationship between these proteins and the genes involved
in dorsal-ventral patterning, such as bmps and Xwnt-8 [33,34].
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